Design and characterization of a metalloproteinase inhibitor-tethered resin for the detection of active MMPs in biological samples

被引:24
作者
Hesek, D
Toth, M
Meroueh, SO
Brown, S
Zhao, H
Sakr, W
Fridman, R [1 ]
Mobashery, S
机构
[1] Wayne State Univ, Sch Med, Dept Pathol, Protease & Canc Program, Detroit, MI 48201 USA
[2] Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA
[3] Univ Notre Dame, Walther Canc Res Ctr, Notre Dame, IN 46556 USA
[4] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA
来源
CHEMISTRY & BIOLOGY | 2006年 / 13卷 / 04期
关键词
D O I
10.1016/j.chembiol.2006.01.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Matrix metalloproteinases (MMPs), zinc-dependent endopeptidases, are implicated in tumor progression. We describe herein the development of a resin-immobilized, broad-spectrum synthetic MMP inhibitor for selective binding of the active forms of MMPs from different experimental samples. We confirmed the activity-based binding of MMPs to the inhibitor-tethered resin with purified human recombinant MMP-2, -9, and -14, samples of cultured cells, and tissue extracts. Our results show that only the free active MMPs, and not the zymogens or MMP/TIMP (enzyme-protein inhibitor) complexes, bound specifically to the resin. In our comparison of benign and carcinoma tissue extracts, we detected active MMP-2 and MMP-14 forms only in the cancerous tissue samples, indicating that a pool of the tumor MMPs is free of endogenous inhibitors (TIMPs), and is thus likely to contribute to proteolytic events that precipitate tumor metastasis.
引用
收藏
页码:379 / 386
页数:8
相关论文
共 58 条
[1]   Matrix metalloproteinase expression in breast cancer [J].
Bartsch, JE ;
Staren, ED ;
Appert, HE .
JOURNAL OF SURGICAL RESEARCH, 2003, 110 (02) :383-392
[2]   Enzyme activity - it's all about image [J].
Baruch, A ;
Jeffery, DA ;
Bogyo, M .
TRENDS IN CELL BIOLOGY, 2004, 14 (01) :29-35
[3]   Effects of angiogenesis inhibitors on multistage carcinogenesis in mice [J].
Bergers, G ;
Javaherian, K ;
Lo, KM ;
Folkman, J ;
Hanahan, D .
SCIENCE, 1999, 284 (5415) :808-812
[4]   TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metal loproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP [J].
Bernardo, MM ;
Fridman, R .
BIOCHEMICAL JOURNAL, 2003, 374 :739-745
[5]   Tissue inhibitors of metalloproteinases: evolution, structure and function [J].
Brew, K ;
Dinakarpandian, D ;
Nagase, H .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2000, 1477 (1-2) :267-283
[6]   EXPRESSION OF ACTIVATED GELATINASE IN HUMAN INVASIVE BREAST-CARCINOMA [J].
BROWN, PD ;
BLOXIDGE, RE ;
ANDERSON, E ;
HOWELL, A .
CLINICAL & EXPERIMENTAL METASTASIS, 1993, 11 (02) :183-189
[7]   Clinical studies with matrix metalloproteinase inhibitors [J].
Brown, PD .
APMIS, 1999, 107 (01) :174-180
[8]   MT1-MMP-dependent neovessel formation within the confines of the three-dimensional extracellular matrix [J].
Chun, TH ;
Sabeh, F ;
Ota, I ;
Murphy, H ;
McDonagh, KT ;
Holmbeck, K ;
Birkedal-Hansen, H ;
Allen, ED ;
Weiss, SJ .
JOURNAL OF CELL BIOLOGY, 2004, 167 (04) :757-767
[9]   Cancer therapy - Matrix metalloproteinase inhibitors and cancer: Trials and tribulations [J].
Coussens, LM ;
Fingleton, B ;
Matrisian, LM .
SCIENCE, 2002, 295 (5564) :2387-2392
[10]   Unexpected effect of matrix metal loproteinase down-regulation on vascular intravasation and metastasis of human fibrosarcoma cells selected in vivo for high rates of dissemination [J].
Deryugina, EI ;
Zijlstra, A ;
Partridge, JJ ;
Kupriyanova, TA ;
Madsen, MA ;
Papagiannakopoulos, T ;
Quigley, JP .
CANCER RESEARCH, 2005, 65 (23) :10959-10969